Search results
Found 6075 matches for
PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.
Postgraduate Diploma in PID and MSc
The University of Oxford 2 year part-time course has been designed to provide comprehensive, in-depth training and excellence in paediatric infectious diseases in Europe. The MSc in Paediatric Infectious Diseases is designed to provide an extension to the Postgraduate Diploma in PID. The MSc is a one-year, part-time programme that involves a laboratory-based research project. For further information please visit www.conted.ox.ac.uk/pid
In the media
Featured media appearances from the HIV research group - a selection of newspaper articles and podcasts.
Study
The Department of Paediatrics is involved in medical sciences teaching in Paediatrics for Undergraduate students of the University of Oxford Medical School, as well as running a number of Postgraduate programmes.